| Literature DB >> 31896847 |
Fatma Gülru Erdogan1, Dilsun Yıldırım2, Gül Aslıhan Çakır Akay1.
Abstract
AIMS ANDEntities:
Keywords: Antifungal unresponsiveness; mold onychomycosis; onychomycosis; treatment failure
Year: 2019 PMID: 31896847 PMCID: PMC6862374 DOI: 10.4103/ijd.IJD_453_18
Source DB: PubMed Journal: Indian J Dermatol ISSN: 0019-5154 Impact factor: 1.494
Figure 1Aspergillus flavus onychomycosis - present for 10 years at the beginning of treatment
Figure 2One week after treatment with citric acid. A room for the cushion is prepared using the blunt edge of a lancet
Figure 3Cushion is placed under the nail
Figure 4One year after the cessation of treatment
Figure 5Subungual Alternaria onychomycosis present for 12 months
Figure 7After 10 months of treatment, the whole nail is cleared
Figure 8Paecilomyces variotii onychomycosis
Figure 9After 8 months of treatment, the nail is cleared
List of clinical, demographic characteristics, and causative agents
| Result of MaldiTof | Number of patients | Age (mean±SD) | Complaint duration (month) (mean±SD) | Type of onychomycosis | Type of previous treatment | Pretreatment OSI (mean±SD) | Posttreatment OSI (mean±SD) | Duration of Citric acid therapy (month) (mean±SD) |
|---|---|---|---|---|---|---|---|---|
| 9 | 54.56±20,44 | 24.0±10,39 | 6 DLS | 3 topical cicloproxolamine citrate | 21.56±9.07 | 2.78±3.34 | 5.44±2.87 | |
| 4 | 41.50±15.86 | 54.00±48.49 | 1 DLS | 3 topical cicloproxolamine citrate | 24.75±14.61 | 0.50±1.00 | 6.50±3.10 | |
| 2 | 51,50±19.09 | 24,00±16.97 | 1 proximal subungual | 1 topical tioconazole | 25.50±13.43 | 0.50±0.70 | 7.50±0.70 | |
| 2 | 52.50±7.77 | 18.00±8.48 | 1 DLS | Topical amorolfine Systemic itraconazole | 21.00±1.41 | 1.00±1.41 | 5.00±1.41 | |
| 1 | 54 | 24 | DLS | Topical ciclopirox olamine citrate | 26 | 0 | 2 | |
| 1 | 39 | 96 | Total dystrophic | Systemic itraconazole, | 30 | 1 | 10 | |
| 1 | 47 | 24 | DLS | Systemic terbinafine | 6 | 0 | 4 |
OSI: Onychomycosis severity index; DLSO: Distal lateral subungual; SD: Standard deviation